Psychedelic Alpha
 | |
| Formerly | Psilocybin Alpha |
|---|---|
| Industry | Psychedelic industry |
| Founded | 2020 |
| Founder | Josh Hardman |
| Website | psychedelicalpha |
Psychedelic Alpha (Pα), formerly known as Psilocybin Alpha, is a website, independent media outlet, and consultancy firm in the area of the psychedelic drug industry.[1][2] The coverage of Psychedelic Alpha includes business and drug development, policy reform, and scientific research in the area of psychedelic drugs, among other topics.[1][2][3] Some of its notable projects include a weekly newsletter,[2] a psychedelic drug development tracker,[4] and a psychedelic law and policy tracker.[3] The founder and editor of Psychedelic Alpha is Josh Hardman, who started the site in 2020.[1][2]
See also
[edit]References
[edit]- 1 2 3 "Interview with Josh Hardman of Psychedelic Alpha". UBC. 15 January 2026. Retrieved 27 March 2026.
- 1 2 3 4 Psychedelics Today (25 January 2022). "PT287 – Josh Hardman – Psychedelic Stocks, Data Privacy, and Drug Development". Psychedelics Today. Retrieved 27 March 2026.
- 1 2 UC Berkeley Center for the Science of Psychedelics (4 December 2024). "BCSP, Psychedelic Alpha, and Calyx Law Launch Psychedelic Law and Policy Tracker". UC Berkeley Center for the Science of Psychedelics. Retrieved 27 March 2026.
- ↑ "Psychedelic Alpha Released Q1 2026 Psychedelic Drug Development Bullseye Charts". Highly Capitalized – We follow the money. 26 February 2026. Retrieved 27 March 2026.